This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through July 6, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
payments: Archive
The Baldwin Insurance Group (BWIN)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
BWINPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Consumer Services Cushion Western Union's Q2 Revenue Drop?
by Zacks Equity Research
WU faces a Q2 revenue decline, but growing Consumer Services and lower expenses could help support earnings despite pressure in money transfers.
WUNegative Net Change MANegative Net Change AXPNegative Net Change SYFNegative Net Change
business-services earnings finance payments
Mastercard Nears Q2 Earnings With Beat Potential, but Should You Buy?
by Kaibalya Pravo Dey
MA heads into Q2 earnings with signs of another beat, but regulatory risks could make investors think twice before buying now.
MANegative Net Change VNegative Net Change AXPNegative Net Change
business-services earnings-outlook earnings-preview finance payments
AXP Q2 Earnings Beat Estimates on Strong Card Member Spending Growth
by Zacks Equity Research
American Express tops Q2 EPS estimates as Card Member spending, net interest income and card fee growth lift revenues despite higher expenses.
AXPNegative Net Change NMRKNegative Net Change VCTRPositive Net Change AAMINegative Net Change
earnings fin-tech finance payments
Visa's Q3 Earnings Could be a Catalyst: Should You Buy Now?
by Kaibalya Pravo Dey
V heads into fiscal Q3 earnings with a strong beat history, rising payment volumes and digital payments growth, but can results justify its premium valuation?
VNegative Net Change MANegative Net Change AXPNegative Net Change
business-services earnings-outlook earnings-preview finance payments
Sky Harbour Group Corporation (SKYH) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
SKYHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Mastercard vs. Affirm: Which Fintech Stock Has More Room to Run?
by Rajshree Sipani
AFRM's faster growth, lower valuation and higher analyst upside give it the edge over MA in the race to capitalize on digital payments.
MANegative Net Change AFRMNegative Net Change
artificial-intelligence blockchain business-services cybersecurity e-commerce fin-tech finance payments saas software
Home BancShares (HOMB)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
HOMBNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Aveanna Healthcare (AVAH) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
AVAHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can AmEx Beat Q2 Earnings on Higher Network Volumes & Interest Income?
by Zacks Equity Research
American Express heads into Q2 earnings with rising network volumes, higher interest income and a favorable earnings setup. Can it deliver another beat?
AXPNegative Net Change BAMNegative Net Change BAPNegative Net Change VIRTPositive Net Change
earnings finance payments